3Tavares PS, Rocon-Albuquerque R Jr, Leite-Moreira AF. Innate immune receptor activation in viral myocarditis: pathophysiologic implications [J]. Rev Port Cardiol, 2010,29 (1) : 57.
4Song HP,Zhang L, Dang YM, et al. The phosphatidylinositol 3- kinase Akt pathway protects cardiomyocytes from ischaemic and hypoxic apoptosis via mitochondriai function [J]. Clin Exp Phar- macol Physiol,2010,37(5) :598.
5Aihara K, lkeda Y, Yogi S, et al. Transforming Growth Factor- Blas a Common Target Molecule for Development of Cardiovascu larDiseases,Renal Insufficiency and Metabolic Syndrome[J]. Car- diolRes Praot,2010,201(1) :175381.
6Villar AV,Cobo M. Llano M. et al. Plasma levels of transforming growth factor-betal reflect left ventrieular remodeling in aortic atenosis[J]. PLns One, 2009,4 ( 12 ) : e8476.
7Gramley F, Lomnzen J, Koellensperger E, el al. Atrial fibrosisand atrial fibrillation:the role of the TGF-β signaling pathway[J]. J Cardiol,2010, 143(3) ,405.
8Li X,Ma C,Dong J,et al. The fibrosis and atrial fibrillation: is the transforming growth factor:betal a candidate etiology of atrial fi- brillation[J].Med Hypot heses,2008,70(2):317.
9Wu YZ, Li SQ, Zu XG, et al. Ginkgo biloba extract improves cor- onary artery circulation in patients with coronary artery disease: contribution of plasma nitric oxide and endothelin 1 [J]. Phyto ther Res,2008,22(6) :734.
